Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New awareness video warns of 'Krokodil' drug addiction
  • USA - English


News provided by

Maltin PR

Oct 20, 2016, 06:05 ET

Share this article

Share toX

Share this article

Share toX

London (PRWEB UK) 20 October 2016 -- Krokodil is a deadly, homemade alternative to heroin that surged through Russia in 2010. After reaching the United States in 2015, the drug is now close to the UK, with recently reported appearances in Germany and Norway. This dangerous ‘heroin moonshine’ is highly toxic and rots the flesh. The drug is very cheap and can be concocted using easily accessible over-the-counter medication. The danger lies in its toxic by-products which are injected into the body resulting in tissue damage. After a short time, the skin necrosis leads to the need for amputation and irreversible damage to the nervous system. Users develop gangrenous, scaly skin resembling that of a crocodile, hence the name ‘Krokodil’. According to experts, Krokodil addicts have a two to thee-year life expectancy, and in some cases the first injection leads directly to death.

In Russia it is estimated that up to a million people are injecting this deadly drug, according to the US website Narconon. 2011 saw 23 times more Krokodil seized by law enforcement since 2009; and within the first three months of 2011, 65 million doses were seized. Krokodil takes roughly 45 minutes to prepare from over-the-counter ingredients. Users then experience a 90-minute-high after which the painful symptoms of withdrawal begin to set in. This short timetable can cause users to get caught in a 24-hour-cycle to avoid the effects of withdrawal. For those addicted to Krokodil withdrawal is much more agonizing than heroin and can last up to one month, causing users to feel almost unbearable pain. Experts dealing with addicts have noted that this drug is one of the strongest levels of addiction and extraordinarily hard to cure.

Yasmin Batliwala, Chair of WDP, said ‘There is a possibility that this drug will begin to be used in the UK as a much cheaper alternative to heroin. The greatest concern is that all the ingredients needed to manufacture this drug are available from pharmacies. Krokodil is highly addictive and destructive, and we must be vigilant about such drugs, and new combinations of drugs, and start to put measures in place for the possibility that it will surface within the UK. Prevention is key, so raising awareness of its potential dangers is a must.’

One man determined to raise awareness of the danger of this drug is filmmaker Romain Demongeot. Demongeot founded prevention-Krokodil.org an organization designed not only to raise awareness about use of the drug, but also to warn people about the poisonous nature of Krokodil. To reinforce his message, Demongeot has written and directed a short film called ‘Krokodil Requiem’, which uses art to raise awareness about this important topic. Inspired by Prokofiev’s, Peter and the Wolf, Krokodil Requiem is a 6-minute short film with a powerful visual and acoustic aesthetic, designed to forcefully portray the dangers of Krokodil. The film, made in collaboration with co-director Sonia Presne, uses a binaural 3D sound experience which amplifies the visual effects, plunging the viewer into a real sonar world.

Demongeot said: “I have used artistic expression to look at this crisis from another angle. Creatively speaking, the idea was to talk about the drug, but from the inside. Prevention films tend to denounce a lot of things, but they don’t explain how a drug addict feels. Dark thoughts, desperation and suicidal thoughts are never mentioned - that’s why we decided to make this short movie, and detail the emotions drug addicts go through when they inject the drug into their systems. More deaths will happen if we do not talk about it”.

Relevant Links
The Making Of
https://www.youtube.com/watch?v=uCjaYqH2A-w
Krokodil Requiem
https://www.youtube.com/watch?v=IGKxOLJWU1Y
Peter and the Wolf
https://www.youtube.com/watch?v=oZ5WMZUbKy4

http://www.prevention-krokodil.org

http://www.wdp.org.uk

About Romain:
Romain Demongeot is the Director and Producer of Krokodil Requiem. After studying Art Direction at ESAG Penninghen College Paris, Romain has worked in advertising and movie direction, working on luxury brand campaigns. He is also the creator of Love 2026 a topical film focusing on climate change.

About Yasmin:
Yasmin Batliwala is the Chair of WDP. She has over two decades of experience in the charity sector, with particular involvement in the areas of drug and alcohol dependency, HIV/AIDS and crime. She has previously undertaken work for the United Nations Office of Drugs and Crime. Yasmin is also CEO of the charity Advocates for International Development.

Lucy Walker, Maltin PR, +44 2072872575, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.